49.24
price down icon1.24%   -0.6631
 
loading

Guardant Health Inc (GH) 最新ニュース

pulisher
Jun 18, 2025

Guardant Health’s Multi-Cancer Detection Test Wins FDA Breakthrough Designation - Medical Product Outsourcing

Jun 18, 2025
pulisher
Jun 17, 2025

Australian biotech uncovers broader view of tumour genetics with liquid biopsy - Mugglehead Magazine

Jun 17, 2025
pulisher
Jun 16, 2025

Insider Sell: Meghan Joyce Sells Shares of Guardant Health Inc (GH) - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

Guardant Health director sells shares worth $157,573 - Investing.com

Jun 16, 2025
pulisher
Jun 16, 2025

Guardant Health Executives Sell Shares - TradingView

Jun 16, 2025
pulisher
Jun 16, 2025

Guardant Health up 4% on Q1 beats, 2025 guidance revenue raise - MSN

Jun 16, 2025
pulisher
Jun 16, 2025

Non-Invasive Cancer Testing Market Forecast | Major Players: Guardant Health, Exact Sciences, Qiagen, Natera Inc. - openPR.com

Jun 16, 2025
pulisher
Jun 16, 2025

Guardant Health (NASDAQ:GH) Given New $65.00 Price Target at Mizuho - MarketBeat

Jun 16, 2025
pulisher
Jun 14, 2025

(GH) Investment Report - news.stocktradersdaily.com

Jun 14, 2025
pulisher
Jun 13, 2025

Mizuho raises Guardant Health price target on positive Shield test outlook - Investing.com Canada

Jun 13, 2025
pulisher
Jun 13, 2025

Guardant Health (GH) Price Target Raised to $65 by Mizuho | GH S - GuruFocus

Jun 13, 2025
pulisher
Jun 12, 2025

Molecular Diagnostics for Cancer Market Research 2025: Advances in Personalized Medicine and Liquid Biopsies Reshape Industry Landscape - GlobeNewswire Inc.

Jun 12, 2025
pulisher
Jun 12, 2025

Guardant Health, Inc. (NASDAQ:GH) Receives $53.29 Consensus PT from Analysts - MarketBeat

Jun 12, 2025
pulisher
Jun 10, 2025

Guardant Health Wins Fast Company's 2025 World Changing Ideas Aw - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Guardant Health Wins Fast Company's 2025 World Changing Ideas Award for Shield Blood Test for Colorectal Cancer Screening | GH Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Guardant Health Wins Fast Company’s 2025 World Changing Ideas Award for Shield Blood Test for Colorectal Cancer Screening - Yahoo Finance

Jun 10, 2025
pulisher
Jun 10, 2025

Circulating Tumor DNA–Guided Risk Stratification in Colorectal Cancer: Evolving Evidence and Future Utility - The ASCO Post

Jun 10, 2025
pulisher
Jun 10, 2025

Insider Sell: Amirali Talasaz Sells 119,284 Shares of Guardant H - GuruFocus

Jun 10, 2025
pulisher
Jun 09, 2025

Guardant Health Inc (GH) Shares Up 4.04% on Jun 9 - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Guardant Health at Goldman Sachs Conference: Strategic Growth Insights By Investing.com - Investing.com Canada

Jun 09, 2025
pulisher
Jun 09, 2025

Transcript : Guardant Health, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 10 - MarketScreener

Jun 09, 2025
pulisher
Jun 09, 2025

New Study Published in ESMO Open Highlights Guardant Reveal's Performance in Detecting Minimal Residual Disease in Patients with Early-Stage Breast Cancer - BioSpace

Jun 09, 2025
pulisher
Jun 09, 2025

New Study Published in ESMO Open Highlights Guardant Reveal's Performance in Detecting Minimal Residual Disease in Patients with Early-Stage Breast Cancer | GH Stock News - GuruFocus

Jun 09, 2025
pulisher
Jun 07, 2025

ARK Investment Acquires 99.6K Shares of Guardant Health (GH) | G - GuruFocus

Jun 07, 2025
pulisher
Jun 06, 2025

Guardant Health, Inc. (GH)’s ctDNA Test Predicts Colon Cancer Recurrence Risk in Stage III Patients - MSN

Jun 06, 2025
pulisher
Jun 06, 2025

Insider Sell: Kumud Kalia Sells 4,000 Shares of Guardant Health Inc (GH) - GuruFocus

Jun 06, 2025
pulisher
Jun 06, 2025

Guardant Health Inc (GH) Shares Up 3.5% on Jun 5 - GuruFocus

Jun 06, 2025
pulisher
Jun 06, 2025

Mackenzie Financial Corp Has $230,000 Holdings in Guardant Health, Inc. (NASDAQ:GH) - Defense World

Jun 06, 2025
pulisher
Jun 06, 2025

Guardant Health Shares Climb on FDA Breakthrough Status for Cancer Detection Test - MSN

Jun 06, 2025
pulisher
Jun 05, 2025

Minimal Residual Disease Testing Market Set to Witness - openPR.com

Jun 05, 2025
pulisher
Jun 05, 2025

Colorectal Cancer Diagnostics Market Size To Boom with Top Key - openPR.com

Jun 05, 2025
pulisher
Jun 04, 2025

ARK Investment Acquires 99.6K Shares of Guardant Health (GH) | GH Stock News - GuruFocus

Jun 04, 2025
pulisher
Jun 04, 2025

Cathie Wood’s ARK sells Palantir and Roblox, buys Veracyte and Guardant - Investing.com Australia

Jun 04, 2025
pulisher
Jun 04, 2025

Cathie Wood’s ARK sells Palantir and Roblox, buys Veracyte and Guardant By Investing.com - Investing.com UK

Jun 04, 2025
pulisher
Jun 04, 2025

Guardant Health, Inc. (GH) Expands Liquid Biopsy to Pinpoint Tumor Origins and Biomarkers - MSN

Jun 04, 2025
pulisher
Jun 04, 2025

Guardant Health gets FDA breakthrough device status for cancer detection test - MSN

Jun 04, 2025
pulisher
Jun 04, 2025

Guardant Health’s MCD test earns FDA breakthrough designation - Yahoo

Jun 04, 2025
pulisher
Jun 04, 2025

111 Capital Purchases Shares of 8,303 Guardant Health, Inc. (NASDAQ:GH) - MarketBeat

Jun 04, 2025
pulisher
Jun 04, 2025

Guardant Health’s cancer test earns FDA breakthrough status By Investing.com - Investing.com South Africa

Jun 04, 2025
pulisher
Jun 03, 2025

Leerink Partners maintains outperform rating for Guardant Health stock By Investing.com - Investing.com Canada

Jun 03, 2025
pulisher
Jun 03, 2025

ARK Investment Acquires 173K Shares of Guardant Health (GH) | GH Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Guardant Health (GH) Stock Surges on FDA Breakthrough Designatio - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Why Guardant Health Stock Surged Nearly 9% Higher Today - MSN

Jun 03, 2025
pulisher
Jun 03, 2025

NCCN Adds 2 Tests to CRC Screening Guidelines - OncLive

Jun 03, 2025
pulisher
Jun 03, 2025

Why Is Cancer Diagnostic Guardant Health Stock Trading Higher On Tuesday?Guardant Health (NASDAQ:GH) - Benzinga

Jun 03, 2025
pulisher
Jun 03, 2025

Guardant Health shares rise following FDA breakthrough designation By Investing.com - Investing.com South Africa

Jun 03, 2025
pulisher
Jun 03, 2025

Guardant Health shares rise following FDA breakthrough designation - Investing.com

Jun 03, 2025
pulisher
Jun 03, 2025

Guardant Health (GH) Gains as FDA Grants Breakthrough Designatio - GuruFocus

Jun 03, 2025
pulisher
Jun 03, 2025

Guardant Health's Shield Multi-Cancer Test Receives FDA Breakthrough Device Designation - marketscreener.com

Jun 03, 2025
pulisher
Jun 03, 2025

Guardant Health’s cancer test earns FDA breakthrough status - Investing.com

Jun 03, 2025
pulisher
Jun 03, 2025

Guardant Health (GH) Receives FDA Breakthrough Designation for Cancer Detection Test | GH Stock News - GuruFocus

Jun 03, 2025
diagnostics_research DGX
$176.31
price down icon 1.21%
diagnostics_research WAT
$352.40
price up icon 0.95%
diagnostics_research LH
$260.81
price up icon 0.75%
$165.11
price down icon 3.13%
diagnostics_research MTD
$1,173.51
price up icon 0.24%
diagnostics_research IQV
$158.54
price down icon 0.33%
大文字化:     |  ボリューム (24 時間):